Unknown

Dataset Information

0

Urinary [TIMP-2]?×?[IGFBP7] and serum procalcitonin to predict and assess the risk for short-term outcomes in septic and non-septic critically ill patients.


ABSTRACT:

Background

Biomarkers can play a critical role by facilitating diagnosis and stratification of disease, as well as assessment or prediction of disease severity. Urinary tissue inhibitor of metalloproteinase-2 and insulin-like growth factor binding protein 7 product ([TIMP-2]?×?[IGFBP7]) predict the development and progression of AKI and recently procalcitonin (PCT), a widely used biomarker for sepsis diagnosis and management, has been associated with AKI occurrence in ICU patients. To assess combinations of [TIMP-2]?×?[IGFBP7] and PCT results for prediction and risk stratification of short-term outcomes in septic and non-septic patients, a retrospective cohort analysis of critically ill patients was performed in a multidisciplinary ICU. ROC curve analysis was used in order to evaluate predictive performance of combined results of [TIMP-2]?×?[IGFBP7] and PCT at the time of admission for AKI development. To verify the utility of adding [TIMP-2]?×?[IGFBP7] and PCT results for risk assessment, we evaluated the predictive value of having a single-marker positivity compared to a double-marker positivity using the widely used cut-off of 0.3 (ng/mL)2/1000 for [TIMP-2]?×?[IGFBP7] and 0.5 ?g/L for PCT. Risk assessment for AKI occurrence within 48 h, acute kidney disease (AKD) and mortality at 7 days was performed by logistic/Cox regression analysis.

Results

433 patients were analysed, of whom 168 had AKI within 48 h (93 septic and 65 non-septic patients). Combination of [TIMP-2]?×?[IGFBP7] and PCT showed a good predictive ability for AKI occurrence (AUC 0.81, 95% CI 0.77-0.86, p?ConclusionsAlthough combining the results of [TIMP-2]?×?[IGFBP7] and PCT may be a useful tool to identify and stratify ICU patients at high risk for septic AKI and short-term adverse outcomes, data should be confirmed in a large prospective study.

SUBMITTER: Godi I 

PROVIDER: S-EPMC7174532 | biostudies-literature | 2020 Apr

REPOSITORIES: biostudies-literature

altmetric image

Publications

Urinary [TIMP-2] × [IGFBP7] and serum procalcitonin to predict and assess the risk for short-term outcomes in septic and non-septic critically ill patients.

Godi Ilaria I   De Rosa Silvia S   Martino Francesca F   Bazzano Simona S   Martin Marina M   Boni Elisa E   Carta Maria Rosa MR   Tamayo Diaz Claudia C   Mari Gaia G   Lorenzin Anna A   de Cal Massimo M   Corradi Valentina V   Caprara Carlotta C   Giavarina Davide D   Ronco Claudio C  

Annals of intensive care 20200421 1


<h4>Background</h4>Biomarkers can play a critical role by facilitating diagnosis and stratification of disease, as well as assessment or prediction of disease severity. Urinary tissue inhibitor of metalloproteinase-2 and insulin-like growth factor binding protein 7 product ([TIMP-2] × [IGFBP7]) predict the development and progression of AKI and recently procalcitonin (PCT), a widely used biomarker for sepsis diagnosis and management, has been associated with AKI occurrence in ICU patients. To as  ...[more]

Similar Datasets

| S-EPMC5690422 | biostudies-literature
| S-EPMC5589717 | biostudies-literature
| S-EPMC8539782 | biostudies-literature
| S-EPMC6490429 | biostudies-literature
| S-EPMC6848119 | biostudies-literature
| S-EPMC5525369 | biostudies-literature
| S-EPMC6410351 | biostudies-literature
| S-EPMC7822524 | biostudies-literature
| S-EPMC6182361 | biostudies-literature
| S-EPMC10399020 | biostudies-literature